You can create a release to package software, along with release notes and links to binary files, for other people to use. Learn more about releases in our docs.

Halloween is about tricks and treats, but who wouldn’t fancy a bit to drink with that? [John Sutley] decided to complete his Halloween party with a drink dispenser looking as though it was dumped by a ...

QUALCOMM Incorporated (NASDAQ:QCOM) is one of the 11 Best American Semiconductor Stocks to Invest In. On October 7, QUALCOMM Incorporated (NASDAQ:QCOM) announced its agreement to acquire Arduino, an ...

Add a beneficial impact on climate change to the long list of benefits being attributed to GLP-1 agonist medicines. An unusual study presented at the European Society of Cardiology (ESC) congress in ...

With competition in the GLP-1 category increasingly cutthroat, Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy was better than Eli Lilly's rival Zepbound at ...

VicGrid has announced the appointment of a new board, chaired by Steve Rieniets whose experience in the energy sector includes senior leadership roles with AGL Energy. Deputy chair is Sarah Clarke and ...

Abstract: In this paper, we analyze the working principle of an arduino. These days many people try to use the arduino because it makes things easier due to the ...

Upload the sketch, and then monitor serial. The example sketch will calibrate the device over 15 seconds, and then print the carbon monoxide ppm once every second to the serial console. In the MQ7 ...

Myocarditis is generally a mild and self-limited consequence of systemic infection of cardiotropic viruses. However, patients can develop a temporary or permanent impairment of cardiac function ...

Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses worldwide, yet it is an entity with incompletely understood pathophysiology and limited therapeutic options. Patients ...

A new meta-analysis from Mattia Galli, MD, PhD, et al., of 21 trials using eight different GLP1-RAs and with nearly 100,000 patients found "conclusive high-certainty evidence" that, vs. controls, the ...